References
- Wu AH, Yu MC, Tseng CC, and Pike MC: Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98, 9–14, 2008.
- Vergne S, Sauvant P, Lamothe V, Chantre P, Asselineau J, et al.: Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr 102, 1642–1653, 2009.
- Nagata C, Takatsuka N, Inaba S, Kawakami N, and Shimizu H: Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 90, 1830–1835, 1998.
- Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, et al.: Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update 15, 423–440, 2009.
- Petrakis NL, Lee MM, Wrensch MR, Ernster VL, Miike R, et al.: Birthplace and yield of nipple aspirate fluid in Chinese women. Cancer Epidemiol Biomarkers Prev 7, 835–839, 1998.
- Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, et al.: Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 13, 1736–1744, 2004.
- Maskarinec G, Morimoto Y, Conroy SM, Pagano IS, and Franke AA: The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women. J Nutr 141, 626–630, 2011.
- Maskarinec G, Takata Y, Franke AA, Williams AE, and Murphy SP: A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134, 3089–3094, 2004.
- Maskarinec G, Morimoto Y, Heak S, Isaki M, Steinbrecher A, et al.: Urinary estrogen metabolites in two soy trials with premenopausal women. Eur J Clin Nutr 66, 1044–1049, 2012.
- Petrakis NL: Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev 15, 188–195, 1993.
- Maskarinec G, Takata Y, Murphy SP, Franke AA, and Kaaks R: Insulin-like growth factor-I in a 2-year soy intervention among premenopausal women. Br J Nutr 94, 362–367, 2005.
- Maskarinec G, Steude JS, Franke AA, and Cooney RV: Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm (Lond) 6, 9, 2009.
- Maskarinec G, Ollberding NJ, Conroy SM, Morimoto Y, Pagano IS, et al.: Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial. Cancer Epidemiol Biomarkers Prev 20, 1815–1821, 2011.
- Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, et al.: Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 18, 2860–2868, 2009.
- Franke AA, Custer LJ, Morimoto Y, Nordt FJ, and Maskarinec G: Analysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS. Anal Bioanal Chem 401, 1319–1330, 2011.
- Franke AA, Hebshi SM, Pagano I, Kono N, Mack WJ, et al.: Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention. Cancer Epidemiol Biomarkers Prev 19, 1775–1783, 2010.
- Maskarinec G, Takata Y, Franke AA, Williams AE, and Murphy SP: A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134, 3089–3094, 2004.
- Littell RC, Henry PR, and Ammerman CB: Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 76, 1216–1231, 1998.
- Wu AH, Stanczyk FZ, Hendrich S, Murphy PA, Zhang C, et al.: Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 82, 1879–1886, 2000.
- Messina M, Nagata C, and Wu AH: Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1–12, 2006.
- Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Le ML, et al.: Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res (Phila) 2, 887–894, 2009.
- Yan L and Spitznagel EL: Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89, 1155–1163, 2009.
- Yan L, Spitznagel EL, and Bosland MC: Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19, 148–158, 2010.
- Maskarinec G and Meng L: An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res 3, 134–141, 2001.
- Takata Y, Maskarinec G, Rinaldi S, Kaaks R, and Nagata C: Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake. Nutr Cancer 56, 136–142, 2006.
- Setchell KD, Brown NM, and Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577–3584, 2002.
- Ferlay J, Soerjomataram I, Ervik M, Forman D, and Bray F: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide 2012. Lyon: International Agency for Cancer Research, 2014. Available at: http://globocan.iarc.fr/Default.aspx
- Messina M and Hilakivi-Clarke L: Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 61, 792–798, 2009.